In both GCs from PCOS patients and DHT-treated KGN cells, melatonin was found to increase the expression of SIRT1 and decrease the expression of PINK1/Parkin at the protein level, which improves mitochondrial dysfunction [48]. Here, PRKN is linked to polycystic ovary syndrome.